138 Chapter 8 ABSTRACT Objective: To assess whether there is a difference in symptom severity at baseline and 24-weeks follow-up between conservatively managed patients with Achilles tendinopathy (AT) with low socioeconomic status (SES) compared to those with high SES. Methods: In this prospective cohort study, 200 patients with AT were included and treated according to current guidelines. We linked a neighborhood SES-indicator based on income, employment, and education level and divided the patient population into quintiles, with Q1 being the highest SES and Q5 the lowest. Symptom severity at baseline and follow-up was assessed using the Victorian Institute of Sports Assessment-Achilles (VISA-A) score. Treatment adherence was not measured. We used a general linear model and the mean VISA-A scores at baseline and at 6, 12- and 24-weeks follow-up were compared between Q1(n=45) and Q5(n=39), while adjusting for age, sex, body mass index (BMI), Ankle Activity Score, symptom duration and baseline VISA-A score. Results: Patients had a median age of 51 years and median BMI of 25.4, 40% were female. 74%, 70% and 58% of the participants completed the VISA-A at 6, 12 and 24 weeks respectively. VISA-A scores at baseline were similar for Q1 and Q5 (43.9 and 41.8, p=0.591). At 24-weeks there was a mean (95% confidence interval) difference of 11.2 (1.021.3, p=0.032) points in favor of Q1 on the VISA-A score. Conclusion: AT patients with low SES may have worse outcomes when treated using the current guidelines. The difference in VISA-A score at 24-weeks is larger than the Minimal Clinically Important Difference and might be clinically relevant, but comes with uncertainty due to large dispersion in the data. Clinicians need to consider the impact of social inequality when developing and implementing treatment plans.
RkJQdWJsaXNoZXIy MTk4NDMw